GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Piramal Pharma Ltd (NSE:PPLPHARMA) » Definitions » Inventories, Raw Materials & Components

Piramal Pharma (NSE:PPLPHARMA) Inventories, Raw Materials & Components : ₹0 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Piramal Pharma Inventories, Raw Materials & Components?

Piramal Pharma's inventories, raw materials & components for the quarter that ended in Mar. 2024 was ₹0 Mil.

Piramal Pharma's annual raw materials increased from Mar. 2022 (₹7,224 Mil) to Mar. 2023 (₹9,005 Mil) but then declined from Mar. 2023 (₹9,005 Mil) to Mar. 2024 (₹0 Mil).


Piramal Pharma Inventories, Raw Materials & Components Historical Data

The historical data trend for Piramal Pharma's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Piramal Pharma Inventories, Raw Materials & Components Chart

Piramal Pharma Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Inventories, Raw Materials & Components
2,391.10 7,223.60 9,004.60 -

Piramal Pharma Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9,004.60 - - - -

Piramal Pharma Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Piramal Pharma (NSE:PPLPHARMA) Business Description

Industry
Traded in Other Exchanges
Address
Piramal Ananta, Agastya Corporate Park, Opposite Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai, MH, IND, 400070
Piramal Pharma Ltd offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries. It includes integrated contract development and manufacturing organization business, complex hospital generics business, and India consumer healthcare business, selling over-the-counter products in India.

Piramal Pharma (NSE:PPLPHARMA) Headlines

No Headlines